Search

Your search keyword '"R. Felten"' showing total 133 results

Search Constraints

Start Over You searched for: Author "R. Felten" Remove constraint Author: "R. Felten"
133 results on '"R. Felten"'

Search Results

101. Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.

102. Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey.

103. Rheumatic presentations of Guillain-Barré syndrome as a diagnostic challenge: A case series.

105. Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.

106. Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS.

107. Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage.

108. Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.

111. Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series.

113. How and why are rheumatologists relevant to COVID-19?

114. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014.

115. At the crossroads of gout and psoriatic arthritis: "psout".

116. Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBase.

117. Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: "All that glitters is not scleroderma renal crisis".

118. [A review of avascular necrosis, of the hip and beyond].

119. Advances in the treatment of systemic lupus erythematosus: From back to the future, to the future and beyond.

120. The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database.

121. The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

122. Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date.

123. Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism.

124. 10 most important contemporary challenges in the management of SLE.

125. The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials.

126. Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.

127. [Still disease with heterozygous MEFV mutation].

128. [Unilateral mydriasis in Lyme neuroborreliosis].

131. An example of US Food and Drug Administration device regulation: medical devices indicated for use in acute ischemic stroke.

132. The significance of diagnostic imaging in acute and chronic brain damage in boxing. A prospective study in amateur boxing using magnetic resonance imaging (MRI).

Catalog

Books, media, physical & digital resources